<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">35</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2011-2-113-120</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">OPPORTUNITIES OF FLOW CYTOMETRY IN DIAGNOSTICS OF INFECTIOUS DISEASES. Part 2</article-title><trans-title-group xml:lang="ru"><trans-title>ВОЗМОЖНОСТИ ПРОТОЧНОЙ ЦИТОФЛЮОРИМЕТРИИ В ДИАГНОСТИКЕ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ. Часть 2</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khaidukov</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Хайдуков</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.б.н., зав. лабораторией физиологии и патологии иммунной системы</p><p>117997, Москва, ул. Миклухо-Маклая, 16/10</p></bio><email>khsv@mail.ibch.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zurochka</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Зурочка</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>khsv@mail.ibch.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Институт биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова РАН, Москва&#13;
&#13;
ФГУ Федеральный Научно-Клинический Центр детской гематологии, онкологии и иммунологии РОСЗДРАВА, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Институт иммунологии и физиологии УрО РАН, г. Екатеринбург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-06-26" publication-format="electronic"><day>26</day><month>06</month><year>2011</year></pub-date><volume>1</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>113</fpage><lpage>120</lpage><history><date date-type="received" iso-8601-date="2014-06-26"><day>26</day><month>06</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-06-26"><day>26</day><month>06</month><year>2014</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Khaidukov S.V., Zurochka A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Хайдуков С.В., Зурочка А.В.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Khaidukov S.V., Zurochka A.V.</copyright-holder><copyright-holder xml:lang="ru">Хайдуков С.В., Зурочка А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/35">https://iimmun.ru/iimm/article/view/35</self-uri><abstract xml:lang="en"><p><bold>Abstract.</bold> Flow cytometry allows estimating quantitative and qualitative structure of populations and subpopulations of immune system cells by using various methodical approaches and a wide spectrum of reagents. For diagnostics the Acquired Immune Deficiency Syndrome (AIDS) caused by a Human Immunodeficiency Virus (HIV) the flow cytometry became irreplaceable. Traditionally, immunologists examine standard model of an estimation of immune dysfunction on the basis of classical markers of Т-cells (CD3, CD4, CD8) at the HIV-infection. But researchers pay less attention to other populations and subpopulations of lymphocytes, such as γδ-, αβ- and CD38+ Т-cells. The quantitative estimation of these parameters from a HIV and AIDS patients enables to see pathogenesis a HIV infection and the prediction of its development from another side.</p><p> </p></abstract><trans-abstract xml:lang="ru"><p><bold>Резюме.</bold> Используя различные методические подходы и широкий спектр реагентов, проточная цитометрия позволяет оценивать количественный и качественный состав популяций и субпопуляций клеток иммунной системы. К инфекциям, для диагностики которых метод проточной цитометрии стал незаменим, относится синдром приобретенного иммунодефицита (СПИД), вызываемый вирусом иммунодефицита человека (ВИЧ). Традиционно при ВИЧ-инфекции иммунологи рассматривают стандартную модель оценки иммунной дисфункции на основании классических маркеров Т-клеток (CD3, CD4, CD8). В то же время исследователи в меньшей степени уделяют внимание другим популяциям и субпопуляциям лимфоцитов, к которым, в первую очередь, относятся γδ-, αβ- и CD38+ Т-клетки. Количественная оценка этих параметров у пациентов с ВИЧ и СПИД дает возможность по новому взглянуть на патогенез ВИЧ-инфекции и прогноз ее течения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>flow cytometry</kwd><kwd>AIDS</kwd><kwd>CD38</kwd><kwd>HIV</kwd><kwd>TcR</kwd><kwd>γδ-T-cells</kwd><kwd>αβ-T-cells</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>проточная цитометрия</kwd><kwd>СПИД</kwd><kwd>CD38</kwd><kwd>ВИЧ, TcR</kwd><kwd>γδ-T-клетки</kwd><kwd>αβ-T-клетки</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Зурочка А.В., Гаврилова Т.В., Шестакова Е.В., Квятковская С.В., Миркина Т.В., Черешнев В.А. Оценка зависимости уровня γδ-Т-клеток у ВИЧ-инфицированных пациентов от уровня CD3+CD4+ Т-лимфоцитов // Мед. иммунол. — 2010. — Т. 12, № 4–5. — С. 425–428.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Зурочка А.В., Гаврилова Т.В., Шестакова Е.В., Квятковская С.В., Распопина И.В., Черешнев В.А. Оценка уровня γδ-Т-лимфоцитов у больных ВИЧ-инфекцией в зависимости от вирусной нагрузки // Росс. иммунолог. журн. — 2010. — Т. 4 (13), № 1. — С. 77–82.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Ситдыкова Ю.Р., Серебровская Л.В., Кравченко А.В. Мониторинг иммунного статуса при ВИЧ-инфекции: дополнительные маркеры и их клиническое значение // Эпидемиол. и инфекц. болезни. — 2008. — № 3 — С. 61–64.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Хайдуков С.В., Зурочка А.В. Возможности проточной цитофлюориметрии в диагностике инфекционных заболеваний. Часть 1 // Инфекц. иммун. — 2011. — Т. 1, № 1. — С. 59–66.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Хайдуков С.В., Зурочка А.В. Вопросы современной проточной цитометрии. Клиническое применение. — Челябинск: Изд-во «Челябинская государственная медицинская академия», 2008. — 195 с.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Хайдуков С.В., Зурочка А.В., Черешнев В.А. Многоцветный цитометрический анализ. Идентификация Т-клеток и их субпопуляций по экспрессии αβ-ТCR и γδ-ТCR // Мед. иммунол. — 2008. — Т. 10, № 2–3. — С. 115–124.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Autran B., Carcelaint G., Li T.S., Blanc C., Mathez D., Tubiana R., Katlama C., Debre P., Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ homeostasis and function in advanced HIV disease // Science. — 1997. — Vol. 277. — P. 112–116.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Battistini L., Borsellino G., Sawicki G., Poccia F., Salvetti M., Ristori G., Brosnan C.F. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors // J. Immunol. — 1997. — Vol. 159, N 8. — P. 3723–3730.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Born W.K., Lahn M., Takeda K., Kanehiro A., O'Brien R.L., Gelfand E.W. Role of gammadelta T cells in protecting normal air way function // Respir. Res. — 2000. — Vol. 1. — P. 151–158.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Boullier S., Dadaglio G., Lafeuillade A. V delta 1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and INF-gamma production but are not selected in lymph nodes // J. Immunol. — 1997. — Vol. 159. — P. 3629–3667.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Bouscarat F., Levacher M., Landman R., Muffat–Joly M., Girard P.-M., Saimot A.G., Brun-Vézinet F., Sinet M. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy // AIDS. — 1998. — Vol. 12 — P. 1267–1273.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Brenner M.B., McLean J., Dialynas D.P., Strominger J.L., Smith J.A., Owen F.L., Seidman J.G., Ip S., Rosen F., Krangel M.S. Identification of a putative second T-cell receptor // Nature. — 1986. — Vol. 322, N 6075. — P. 145–149.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Chen J., Niu H., He W., Ba D. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes // Int. Arch. Allergy Immunol. — 2001. — Vol. 125. — P. 256–263.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Chen Z.W., Letvin N.L. Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm // Trends Immunol. — 2003. — Vol. 24. — P. 213–219.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Dechanet J., Merville P., Lim A. Implication of γδ T cells in human immune response to cytomegalovirus // J. Clin. Invest. — 1999. — Vol. 103. — P. 1437–1449.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	.Dieli F., Troye-Blomberg M., Ivanyi J., Fournié J.J., Krensky A.M., Bonneville M., Peyrat M.A., Caccamo N., Sireci G., Salerno A. Granulysindependent killing of intracellular and extracellular Mycobacterium tuberculosis by gamma9/Vdelta2 T lymphocytes // J. Infect. Dis. — 2001. — Vol. 184. — P. 1082–1085.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Ferbas J. Perspectives on the role of CD8 and factors and cytotoxic T lymphocytes during HIV infection // AIDS Res. Hum. Retrov. — 1998. — Vol. 14. — P. 153–160.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Ferrarini M., Ferrero E., Dagna L., Poggi A., Zocch M.R. Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer // Trends Immunol. — 2002. — Vol. 23. — P. 14 –18.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults // JAMA. — 1993. – Vol. 269, N 6. — P. 729–730.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Fujimiya Y., Suzuki Y., Katakura R., Miyagi T., Yamaguchi T., Yoshimoto T., Ebina T. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(–) gammadelta T cells from glioblastoma patients // Clin. Cancer. Res. — 1997. — Vol. 3, N 4. — P. 633–643.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells // Science. — 2001. — Vol. 294. — P. 605–609.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Ichikawa Y., Shimizu H., Yoshida M., Takaya M., Arimori S. T cells bearing gamma/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sjogren’s syndrome // Clin. Exp. Rheumatol. — 1991. — Vol. 9. — P. 603–609.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Ichikawa Y., Shimizu H., Yoshida M., Takaya M., Arimori S. T cells bearing gamma/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sjogren’s syndrome // Clin. Exp. Rheumatol. — 1991. — Vol. 9. — P. 603–609.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	Kabelitz D., Wesch D. Role of gamma delta T-lymphocytes in HIV infection // Eur. J. Med. Res. — 2001. — Vol. 6. — P. 169 –174.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Kato Y., Tanaka Y., Miyagawa F., Yamashita S., Minato N. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens // J. Immunol. — 2001. — 167. — P. 5092–5098.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Kawashima T., Norose Y, Watanabe Y, Enomoto Y., Narazaki H., Watari E., Tanaka S., Takahashi H., Yano I., Brenner M.B., Sugita M. Major CD8 T cell response to live bacillus Calmette-Gueґrin is mediated by CD1 molecules // J. Immunol. — 2003. — Vol. 170. — P. 5345–5348.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Kestens L., Vanham G., Gigase P., Young G., Hannet I., Vanlangendonck F., Hulstaert F. Expression of activation antigens, HLA- DR and CD38, on CD8 lymphocytes during HIV-1 infection // AIDS. — 1992. — Vol. 6 — P. 793–797.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Kobayashi H., Tanaka Y., Yagi J., Toma H., Uchyama T. Gamma/delta T cells provide innate immunity against renal cell carcinoma // Cancer. Immunol. Immunother. — 2001. — Vol. 50. — P. 115–124.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	Komano H., Fujiurat Y., Kawaguch M., Matsumoto S., Hashimoto Y., Obana S., Mombaerts P., Tonegawa S., Yamamoto H., Itohara S., Nanno M., Ishikawa H. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells // Proc. Natl. Acad. Sci. USA. — 1995. — Vol. 92. — P. 6147–6151.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	Kosub D.A., Lehrman G., Milush J.M. Gamma/delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections // J. Virol. — 2008. — Vol. 82. — P. 1155–1165.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Kretowski A., Mysliwiec J., Szelachowska M., Turows ki D., Wysocka J., Kowalska I., Kinalska I. Gammadelta T-cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B-cells impairment // Immunol. Lett. — 1999. — Vol. 68. — P. 289–293.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	.Lafarge X., Merville P., Cazin M.C., Bergé F., Potaux L., Moreau J.F., Déchanet-Merville J. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role // J. Infect. Dis. — 2001. — Vol. 184. — P. 533–541.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Lambert C., Genin C. CD3 bright lymphocyte population reveal gam madelta T cells // Cytometr y. — 2004. — Vol. 61, N 1. — P. 45–53.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Lahn M., Kanehiro A., Takeda K., Joetham A., Schwarze J., Köhler G., O’Brien R., Gelfand E.W., Born W. Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells // Nat. Med. — 1999. — Vol. 5. — P. 1150–1156.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Lehner T., Mitchell E., Bergmeier L., Singh M., Spallek R., Cranage M., Hall G., Dennis M., Villinger F., Wang Y. The role of gammadelta T cells in generating antiviral factors and beta-chemo kines in protection against mucosal simian immunodeficiency virus infection // Eur. J. Immunol. — 2000. — Vol. 30. — P. 2245–2255.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Li H., Peng H., Ma P., Pauza D., Shao Y. Association between Vγ2Vδ2 T cells and disease progression after infection with closely-related viral strains of HIV in China // Clin. Infect. Dis. — 2008. — Vol. 46 — P. 1466 –1472.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Mandy F.F., Nicholson J.K., McDougal J.S. CDC. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention // MMWR Recomm Rep. — 2003. — Vol. 52 (RR02). — P. 1–13.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Martini F., Urso R., Gioia C. Gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy // Immunology. — 2000. — Vol. 100. — P. 481–486.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.	McClanahan J., Fukushima P.I., Stetler-Stevenson M. Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: a diagnostic dilemma in flow cytometry // Cytometry. — 1999. — Vol. 38. — P. 280–285.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.	Mogues T., Goodrich M.E, Ryan L., LaCourse R., North R.J. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice // J. Exp. Med. — 2001. — Vol. 193. — P. 271–280.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.	Moore T.A., Moore B.B., Newstead M.W., Standiford T.J. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia // J. Immunol. — 2000. — Vol. 165. — P. 2643–2650.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.	Morita C.T., Beckman E.M., Bukowski J.F., Tanaka Y., Band H., Bloom B.R., Golan D.E.,</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.	Brenner M.B. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ-T cells // Immunity. — 1995. — Vol. 3. — P. 495–507.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.	Morita C.T., Lee H.K., Leslie D.S., Tanaka Y., Bukowski J.F., Märker-Hermann E. Recognition of nonpeptide prenyl pyrophosphate antigens by human γδ-T cells // Microbes. Infect. — 1999. — Vol. 1. — P. 175–186.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.	Morita C.T., Mariuzza R.A., Brenner M.B. Antigen recognition by human γδ-T cells: pattern recognition by the adaptive immune system // Springer. Semin. Immunopathol. — 2000. — Vol. 22. — P. 191–217.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.	Morita C.T., Tanaka Y., Bloom B.R., Brenner M.B. Direct presentation of non-peptide prenyl pyrophosphate antigens to human γδ-T cells // Res. Immunol. — 1996. — Vol. 147. — P. 347–353. . 64Nunnari G. Do Vγ2Vδ2 T cells influence HIV disease progression? // Clin. Infect. Dis. — 2008. — Vol. 46. — P. 1473–1475.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.	Pawelec G., Sayers T., Busch F. Regulation of normal myelopoiesis and chronic myelogenous leukemia cell proliferation through a non-cytotoxic mechanism by a γδ cell clone // M. Immunol. Lett. — 1989. — Vol. 22. — P. 199–204.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.	Pellegrin J.L., Taupin J.L., Dupon M., Ragnaud J.M., Maugein J., Bonneville M., Moreau J.F. Gammadelta T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients // Int. Immunol. — 1999. — Vol. 11. — P. 1475–1478.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49.	Poles M.A., Barsoum S., Yu W. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy // J. Virol. — 2003. — Vol. 77. — P. 10456–10467.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50.	Robak E., Blonski J.Z., Bartkowiak J., Niewiadomska H., Sysa-Jedrzejowska A., Robak T. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus // Mediators Inflamm. — 1999. — Vol. 8. — P. 305–312.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51.	Saito T., Hochstenbach F., Marusic-Galesic S., Kruisbeek A.M., Brenner M., Germain R.N. Surface expression of only gamma delta and/or alpha beta T cell receptor heterodimers by cells with four (alpha, beta, gamma, delta) functional receptor chains // J. Exp. Med. — 1988. — Vol. 168, N 3. — P. 1003–1020.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52.	Schramm C.M., Puddington L., Yiamouyiannis C.A., Lingenheld E.G., Whiteley H.E., Wolyniec W.W., Noonan T.C., Thrall R.S. Proinflammatory roles of T-cell receptor (TCR)gammadelta and TCRalphabeta lymphocytes in a murine model of asthma // Am. J. Respir. Cell. Mol. Biol. — 2000. — Vol. 22. — P. 218–225.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53.	Selin L.K., Santolucito P.A., Pinto A.K., SzomolanyiTsuda E., Welsh R.M. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells // J. Immunol. — 2001. — Vol. 166. — P. 6784–6794.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54.	Sindhu S.T., Ahmad R., Morisset R., Ahmad A., Menezes J. Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load // J. Virol. — 2003. — Vol. 77. — P. 1848–1855.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55.	Yamashita N., Kaneoka H., Kaneko S., Takeno M., Oneda K., Koizumi H., Kogure M., Inaba G., Sakane T. Role of gammadelta T lymphocytes in the development of Behet’s disease // Clin. Exp. Immunol. — 1997. — Vol. 107, N 2. — P. 241–247.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56.	Yin Z., Craft J. Gamma delta T cells in autoimmunity // Springer Semin. Immunopathol. — 2000. — Vol. 22. — P. 311–320.</mixed-citation></ref></ref-list></back></article>
